作者: Luana Fianchi , Annamaria Nosari , Lorella Melillo , Rosa Fanci , Anna Candoni
DOI: 10.3324/%X
关键词:
摘要: BACKGROUND AND OBJECTIVES: The aim of this study was to evaluate the incidence and outcome invasive fungal infections (IFI) in patients with hematologic malignancies. DESIGN METHODS: This a retrospective cohort admitted between 1999 2003 18 hematology wards Italy. Each participating center provided information on all newly diagnosed malignancies during survery period episodes IFI experienced by these patients. RESULTS: formed 11,802 malignacies: acute leukemia (myeloid 3012, lymphoid 1173), chronic 596, 1104), lymphoma (Hodgkin's 844, non-Hodgkin's 3457), or multiple myeloma (1616). There were 538 proven probable (4.6%); 373 (69%) occurred myeloid leukemia. Over half (346/538) caused molds (2.9%), most cases Aspergillus spp. (310/346). 192 yeast (1.6%) included 175 candidemia. Overall IFI-attributable mortality rates 2% (209/11802) 39% (209/538), respectively. highest associated zygomycosis (64%) followed fusariosis (53%), aspergillosis (42%), candidemia (33%). INTERPRETATION CONCLUSIONS: Patients are currently at higher risk than yeasts, is among spp still common pathogens, Candida Other agents rare. attributable rate for has dropped from 60-70% approximately 40%. Candidemia-related remains within 30-40% range reported literature although decreased.